Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

BACKGROUND: Many cancer patients who receive chemotherapy experience adverse drug effects. Pharmacogenomics (PGx) has promise to personalize chemotherapy drug dosing to maximize efficacy and safety. Fluoropyrimidines and irinotecan have well-known germline PGx associations. At our institution, we ha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Reizine, Natalie, Vokes, Everett E., Liu, Ping, Truong, Tien M., Nanda, Rita, Fleming, Gini F., Catenacci, Daniel V.T., Pearson, Alexander T., Parsad, Sandeep, Danahey, Keith, van Wijk, Xander M. R., Yeo, Kiang-Teck J., Ratain, Mark J., O’Donnell, Peter H.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7750903/
https://ncbi.nlm.nih.gov/pubmed/33414846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920974118
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars